Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)
JPY 57.0
(0.0%)
JPY 57.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 36 Million JPY | 384.33% |
| 2022 | 7.43 Million JPY | 19660.53% |
| 2021 | -38 Thousand JPY | 99.4% |
| 2020 | -6.3 Million JPY | 66.12% |
| 2019 | -18.61 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 49.02 Million JPY | 33.04% |
| 2024 Q2 | 61.29 Million JPY | 25.04% |
| 2023 FY | 36.84 Million JPY | 395.75% |
| 2023 Q2 | 8.12 Million JPY | 8.58% |
| 2023 Q1 | 7.48 Million JPY | 0.63% |
| 2023 Q3 | 14.65 Million JPY | 80.44% |
| 2023 Q4 | 36.84 Million JPY | 151.44% |
| 2022 Q3 | 10.42 Million JPY | 0.0% |
| 2022 Q4 | 7.43 Million JPY | -28.71% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 94.729% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -100.792% |
| GNI Group Ltd. | 2.33 Billion JPY | 98.455% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 98.384% |
| MEDINET Co., Ltd. | 67.48 Million JPY | 46.652% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 96.788% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 65.229% |
| AnGes, Inc. | 1.61 Billion JPY | 97.772% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | 51.351% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 98.76% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 88.817% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -19465.217% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 74.311% |
| CanBas Co., Ltd. | 728 Thousand JPY | -4845.055% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 59.027% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 75.666% |
| Chiome Bioscience Inc. | 64.1 Million JPY | 43.844% |
| Kidswell Bio Corporation | 875.65 Million JPY | 95.889% |
| PeptiDream Inc. | 2.4 Billion JPY | 98.503% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -573.905% |
| Ribomic Inc. | 2.27 Million JPY | -1483.113% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -3599999900.0% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -24.138% |
| CellSource Co., Ltd. | 305.92 Million JPY | 88.232% |
| FunPep Company Limited | 25.54 Million JPY | -40.95% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 90.111% |
| Stella Pharma Corporation | 1.11 Billion JPY | 96.775% |
| TMS Co., Ltd. | 50.02 Million JPY | 28.036% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -72.241% |
| Cuorips Inc. | 1.04 Million JPY | -3351.582% |
| K Pharma,Inc. | 10.79 Million JPY | -233.519% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.696% |
| ReproCELL Incorporated | 248.14 Million JPY | 85.492% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 92.01% |
| StemCell Institute Inc. | 42.26 Million JPY | 14.817% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 84.25% |
| CellSeed Inc. | 46.19 Million JPY | 22.063% |